Karyopharm Therapeutics Inc. (KPTI)

NASDAQ: KPTI · IEX Real-Time Price · USD

1.060

0.00 (0.00%)

At close: Apr 26, 2024, 4:00 PM

1.080

+0.020 (1.89%)

After-hours: Apr 26, 2024, 6:55 PM EDT

Karyopharm Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2011
Revenue	146.03	157.07	209.82	108.09	40.89	30.34	1.61	0.15	0.25	0.23	Upgrade
Revenue Growth (YoY)	-7.03%	-25.14%	94.12%	164.31%	34.80%	1790.09%	942.21%	-38.40%	9.17%	-40.83%	Upgrade
Cost of Revenue	4.94	5.21	3.4	2.71	2.41	0	0	0	0	0	Upgrade
Gross Profit	141.09	151.86	206.42	105.38	38.49	30.34	1.61	0.15	0.25	0.23	Upgrade
Selling, General & Admin	131.88	145.4	143.85	126.42	105.42	48.85	24.87	23.95	21.58	15.95	Upgrade
Research & Development	138.75	148.66	160.84	150.81	122.34	161.37	107.27	86.94	97.74	60.13	Upgrade
Operating Expenses	270.63	294.06	304.69	277.23	227.76	210.22	132.14	110.89	119.33	76.08	Upgrade
Operating Income	-129.54	-142.2	-98.27	-171.85	-189.28	-179.88	-130.54	-110.73	-119.08	-75.85	Upgrade
Interest Expense / Income	23.82	25	26.05	27.14	15.65	2.49	0	0	0	0	Upgrade
Other Expense / Income	-10.59	-2.28	-0.5	-3.03	-5.37	-4	-1.62	-1.29	-0.9	-0.07	Upgrade
Pretax Income	-142.78	-164.92	-123.82	-195.96	-199.55	-178.38	-128.92	-109.44	-118.18	-75.78	Upgrade
Income Tax	0.32	0.37	0.27	0.31	0.04	0.03	0.06	0.14	0	0	Upgrade
Net Income	-143.1	-165.29	-124.09	-196.27	-199.59	-178.41	-128.98	-109.58	-118.18	-75.78	Upgrade
Shares Outstanding (Basic)	114	82	75	72	62	57	46	38	36	31	Upgrade
Shares Outstanding (Diluted)	114	82	75	72	62	57	46	38	36	31	Upgrade
Shares Change	39.51%	8.84%	4.41%	16.28%	9.11%	23.70%	22.32%	5.34%	14.40%	413.14%	Upgrade
EPS (Basic)	-1.25	-2.02	-1.65	-2.72	-3.22	-3.14	-2.81	-2.92	-3.32	-2.43	Upgrade
EPS (Diluted)	-1.25	-2.02	-1.65	-2.72	-3.22	-3.14	-2.81	-2.92	-3.32	-2.43	Upgrade
Free Cash Flow	-92.72	-149.67	-107.33	-160.38	-191.03	-161.48	-73.78	-84.46	-95.45	-54.28	Upgrade
Free Cash Flow Per Share	-0.81	-1.83	-1.43	-2.23	-3.08	-2.84	-1.61	-2.25	-2.68	-1.74	Upgrade
Gross Margin	96.62%	96.68%	98.38%	97.50%	94.11%	100.00%	100.00%	100.00%	100.00%	100.00%	Upgrade
Operating Margin	-88.71%	-90.53%	-46.84%	-159.00%	-462.85%	-592.97%	-8133.21%	-71903.90%	-47630.40%	-33120.52%	Upgrade
Profit Margin	-97.99%	-105.23%	-59.14%	-181.59%	-488.08%	-588.10%	-8036.39%	-71153.90%	-47272.40%	-33090.39%	Upgrade
Free Cash Flow Margin	-63.49%	-95.29%	-51.15%	-148.38%	-467.14%	-532.30%	-4596.82%	-54844.81%	-38178.00%	-23703.49%	Upgrade
EBITDA	-118.42	-139.31	-96.99	-167.85	-182.93	-175.15	-128.21	-108.72	-117.55	-75.45	Upgrade
EBITDA Margin	-81.09%	-88.69%	-46.22%	-155.30%	-447.34%	-577.38%	-7988.04%	-70598.05%	-47018.80%	-32948.91%	Upgrade
Depreciation & Amortization	0.53	0.62	0.79	0.97	0.97	0.74	0.71	0.72	0.63	0.32	Upgrade
EBIT	-118.95	-139.93	-97.77	-168.82	-183.9	-175.89	-128.92	-109.44	-118.18	-75.78	Upgrade
EBIT Margin	-81.46%	-89.08%	-46.60%	-156.20%	-449.72%	-579.80%	-8032.46%	-71063.64%	-47272.40%	-33089.96%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).